Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Dupilumab helps children with alopecia areata regrow hair safely.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Dupilumab can both heal and cause hair loss.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.